Navigation Links
Unigene Provides 2012 Business Outlook
Date:1/9/2012

program
  • Continue to build a robust portfolio of feasibility programs with various pharmaceutical companies evaluating Unigene's industry-leading Peptelligence™ platform for oral delivery of proprietary peptides across a broad spectrum of therapeutic areas
  • Convert at least one Peptelligence™ feasibility study into a definitive license agreement associated with significant milestones and royalties
  • File an IND and begin Phase 1 clinical testing of Unigene's lead metabolic peptide, UGP281, targeting patients with morbid obesity
  • Select lead molecule for Type 2 diabetes indication under joint development vehicle (JDV) with Nordic Bioscience
  • Announce preclinical results for Type 2 diabetes indication under JDV with Nordic Bioscience
  • Palmer continued, "We have established Unigene as the oral peptide delivery innovator and partner-of-choice, and we are now ideally positioned to capitalize on the numerous opportunities our industry leading oral peptide delivery platform can realize in 2012.  In addition, we intend to secure a superb development and commercialization partner for our oral PTH program, a high-value asset with the potential to provide a more compliant and patient friendly therapy for the estimated 75 million osteoporosis sufferers worldwide."

    Palmer concluded, "Prospects for the successful turnaround and long-term future of Unigene have never been brighter or more realizable.  Given this cautious optimism and confidence, all members of Unigene's senior management team and I, along with our Board of Directors, have chosen to increase our personal investments in Unigene, to demonstrate our strong commitment to the Company and our belief in our ability to execute our targeted growth strategy in 2012."

    Unigene Therapeutics Outlook

    Unigene is focused on advancing its own pipeline of novel, proprietary peptide product candidates focused on metabolic disease
    '/>"/>

    SOURCE Unigene Laboratories, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
    2. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
    3. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
    4. Unigene Reports Third Quarter 2011 Financial Results
    5. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
    6. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
    7. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
    8. VIVUS Provides Qnexa Regulatory Update
    9. New Product Planning Excellence Services Program Provides Road Map for Clinical Development Success in the Pharmaceutical Industry
    10. ViroPharma Provides 2012 Outlook
    11. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... , Sept. 30, 2014  eHealth, electronic access ... and access of this information, has become a ... however, that has not translated into user-friendly, effective ... Photo - http://photos.prnewswire.com/prnh/20140929/149123 ... few years developing MWD® Health Manager iEHR, a ...
    (Date:9/30/2014)... Sept. 30, 2014  RFID Journal announced today that registration ... www.rfidjournalevents.com/healthcare ), the premier industry event focused on the ... care sector. The conference and exhibition will be held ... Place in Chicago, Ill. ... executives explaining how they use RFID to improve asset-utilization ...
    (Date:9/30/2014)... , Sept. 30, 2014  Come fall, many ... "who" or "what" they want to be for Halloween. ... their look with decorative contact lenses bought without a ... of year that people purchase and wear contact lenses ... 2013 American Eye-Q ® consumer survey, 17 percent ...
    Breaking Medicine Technology:MWD Challenges the Big eHealth Players With New Software for Your Smartphone 2Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 2Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 3The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3
    ... WIRE)--May 15, 2007 - Synthetic Blood,International, Inc. ... analysis of its Phase IIa study with ... line with preliminary,study results announced in December ... of increasing patients' oxygen,tension levels compared with ...
    ... WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ... the Company's products,will be presented at Digestive Disease ... Digestive Disease Week is considered the,largest and most ... Every year it attracts more than 16,000 physicians,researchers ...
    Cached Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
    (Date:9/30/2014)... Coast Dental and Orthodontics is ... practice, located at 1010 Shaw Avenue in Clovis, CA. ... services , and specialty dental care including orthodontics, endodontics, ... and convenient dental care, our Clovis dentists also strive ... Coast Dental at 559-777-6113 to schedule an appointment. , ...
    (Date:9/30/2014)... how resveratrol, an antioxidant derived from grapes and found ... that causes acne. , The team also found that ... may enhance the drug,s ability to kill the bacteria ... the current online edition of the journal Dermatology ... resveratrol and benzoyl peroxide attack the acne bacteria, called ...
    (Date:9/30/2014)... Michigan are pleased to announce an agreement to publish ... Endocrinology , which is now open for submissions and ... , The journal is led by Editor-in-Chief, Meng ... Metabolism, Endocrinology, and Diabetes, at the University of Michigan, ... international Editorial Board. , Clinical Diabetes and ...
    (Date:9/30/2014)... valuable procedure by which to screen for the ... healthy Americans who do undergo this sometimes uncomfortable ... actually should. Gina Kruse of Massachusetts General ... endoscopists stick to the national guidelines more closely. ... General Internal Medicine , published by Springer. ...
    (Date:9/30/2014)... September 30, 2014 MyServer2Go.com ... as the Best VPS Hosting this year for its ... as affordable price. , MyServer2Go.com is a professional ... VPS hosting services. And this announcement will help webmasters ... According to MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is one ...
    Breaking Medicine News(10 mins):Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:Antioxidant found in grapes uncorks new targets for acne treatment 2Health News:Antioxidant found in grapes uncorks new targets for acne treatment 3Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:Americans undergo colonoscopies too often, study finds 2Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2
    ... of a woman diagnosed with breast cancer is 63, so ... older patient population. But older women with breast cancer are ... the effects of chemotherapy used in addition to other therapies ... May 14 issue of The New England Journal of ...
    ... (NYSE Alternext US: ADL), a US-based pharmaceutical company with ... into two distinct five-year marketing and distribution agreements with ... provider, whereby GenWay Biotech will ... the US and Canada. The partnership significantly advances ...
    ... award winning mobile health care solution - OnCare by Gearworks - will ... Association of America (VNAA) 27th Annual Meeting from May 14-16, 2009 in ... ... -- Gearworks , a leading provider of location-based mobile business applications, ...
    ... WASHINGTON, May 13 "On behalf of the 157,000 ... I would like to thank Congressman Mike Simpson for ... -- a resolution yesterday congratulating the ADA on its ... vigilant on behalf of its members, the ADA nonetheless ...
    ... XLHealth, owner and operator of Care Improvement Plus, one ... Needs Plans, views the Social Security and Medicare Trustees ... address the needs of the chronically ill. Along with ... timeline toward Medicare insolvency includes spending associated with chronically ...
    ... American Nurses Pledges Support for Legislation SILVER SPRING, Md., ... vowed support for legislation that will protect nurses from ... Health Care Worker Protection Act of 2009 (H.R. 2381), ... to develop and implement a standard to eliminate manual ...
    Cached Medicine News:Health News:Study shows chemotherapy improves survival among older breast cancer patients 2Health News:AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada 2Health News:AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada 3Health News:AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada 4Health News:Gearworks to Exhibit OnCare at VNAA 27th Annual Meeting 2Health News:Gearworks to Exhibit OnCare at VNAA 27th Annual Meeting 3Health News:Statement by American Dental Association President John S. Findley on Passage of H.Res. 204, a Congressional Resolution Congratulating the Association for its 150 Years of Service 2Health News:XLHealth Statement on Social Security and Medicare Trustees Report 2Health News:Common-Sense Patient Handling Bill Protects Patients and Nurses 2
    Polyester ribbon impregnated with conjugated Protein G - .13 OD per sq. cm....
    Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
    ... glass (1.5x) Gonio lens will enable visualization ... 4 mirror lens is the industry preferred ... and features : , Crispest, clearest ... previously unattainable with Gonio lenses., 4 equally ...
    Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
    Medicine Products: